124 related articles for article (PubMed ID: 38850724)
21. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
[TBL] [Abstract][Full Text] [Related]
23. Where does TIPS fit in the management of patients with cirrhosis?
García-Pagán JC; Saffo S; Mandorfer M; Garcia-Tsao G
JHEP Rep; 2020 Aug; 2(4):100122. PubMed ID: 32671331
[TBL] [Abstract][Full Text] [Related]
24. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
[TBL] [Abstract][Full Text] [Related]
25. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study.
Wang C; Wang Y; Zhao J; Yang C; Zhu X; Niu H; Sun J; Xiong B
Heliyon; 2024 Jan; 10(1):e23455. PubMed ID: 38163189
[TBL] [Abstract][Full Text] [Related]
26. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
[No Abstract] [Full Text] [Related]
27. [Study on the comparative analysis of the efficacy of transmesenteric vein extrahepatic portosystemic shunt and transjugular intrahepatic portosystemic shunt in the treatment of cavernous transformation of portal vein].
Zhu YD; Li WX; Cui MZ; Wang H; Yang HP; Zhai ST
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):90-95. PubMed ID: 36948855
[No Abstract] [Full Text] [Related]
28. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
[TBL] [Abstract][Full Text] [Related]
29. Pre-transjugular-intrahepatic-portosystemic-shunt measurement of hepatic venous pressure gradient and its clinical application: A comparison study.
Wang XX; Yin XC; Gu LH; Guo HW; Cheng Y; Liu Y; Xiao JQ; Wang Y; Zhang W; Zou XP; Wang L; Zhang M; Zhu-Ge YZ; Zhang F
World J Gastroenterol; 2023 Jun; 29(22):3519-3533. PubMed ID: 37389231
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.
Yin X; Zhang F; Xiao J; Wang Y; He Q; Zhu H; Leng X; Zou X; Zhang M; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1264-1269. PubMed ID: 31136318
[TBL] [Abstract][Full Text] [Related]
31. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
[TBL] [Abstract][Full Text] [Related]
32. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases].
Zhou H; Yao X; Tang SH; Xie M; Feng ZS; Qin JP
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):54-59. PubMed ID: 33541024
[No Abstract] [Full Text] [Related]
34. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children.
Monroe EJ; Michalsky WS; Koo KSH; Shivaram GM; Hage AN; Hsu EK; Horslen SP; Chick JFB
Pediatr Radiol; 2020 Oct; 50(11):1579-1586. PubMed ID: 32583092
[TBL] [Abstract][Full Text] [Related]
36. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).
Routhu M; Safka V; Routhu SK; Fejfar T; Jirkovsky V; Krajina A; Cermakova E; Hosak L; Hulek P
Ann Hepatol; 2017; 16(1):140-148. PubMed ID: 28051803
[TBL] [Abstract][Full Text] [Related]
37. Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
Lv Y; Chen H; Luo B; Bai W; Li K; Wang Z; Xia D; Guo W; Wang Q; Li X; Yuan J; Cai H; Xia J; Yin Z; Fan D; Han G
Hepatology; 2022 Sep; 76(3):676-688. PubMed ID: 35266571
[TBL] [Abstract][Full Text] [Related]
38. [Study of portal venous pressure gradient to predict high-hepatic encephalopathy-risk population post TIPS].
Zhang H; Pan JJ; Jiang XF; Lin JJ; Lu LJ; Chu JG
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):72-74. PubMed ID: 33548970
[TBL] [Abstract][Full Text] [Related]
39. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.
Guo H; Zhang F; Yin X; Zhang M; Xiao J; Wang Y; Zhang B; Zhang W; Zou X; Zhuge Y
Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1427-1435. PubMed ID: 32868650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
